Elevated triglycerides and low HDL cholesterol in transgenic mice expressing human apolipoprotein A-I(Milano)

Atherosclerosis

Volumn 136, Issue 1, 1998, Pages 139-146

  Chiesa, G ^a   Stoltzfus, L J ^b   Michelagnoli, S ^a   Bielicki, J K ^b   Santi, M ^a   Forte, T M ^b   Sirtori, C R ^a   Franceschini, G ^a   Rubin, E M ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

Apolipoprotein A I(Milano); Apolipoproteins; High density lipoproteins; Molecular variants; Transgenic mice

Indexed keywords

APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ANIMAL MODEL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; FAST PROTEIN LIQUID CHROMATOGRAPHY; GENE MUTATION; HUMAN; HYPERTRIGLYCERIDEMIA; LIPOPROTEIN BLOOD LEVEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0031827934     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(97)00195-0     Document Type: Article

References (26)

1. Gordon D.J., Probstfeld J.L., Garrison R.J., Neaton J.D., Castelli W.P., Knoke J.D., Jacobs J.R., Bangdlwala S., Tyroler A. High density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation. 79:1989;8.
2. Puchois P., Kandossi A., Fievet P., Fourrier J.L., Bertrand M., Koren E., Fruchard J.C. Apolipoprotein A-I containing lipoproteins in coronary artery disease. Atherosclerosis. 68:1987;35.
3. Franceschini G. Apolipoprotein functions in health and disease: insights from natural mutations. Eur J Clin Invest. 26:1996;733.
4. Milano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modofications and without clinical atherosclerosis in an italian family. J Clin Invest. 66:1980;892.
5. Milano apoprotein: identification of the complete kindred and evidence of a dominant genetic transmission. Am J Hum Genet. 37:1985;1083.
6. Milano. Detection of normal A-I in affected subject and evidence for a cysteine for arginine substitution in the variant A-I. J Biol Chem. 258:1983;2508.
7. Milano. Correlation between high density lipoprotein subclass distribution and triglyceridemia. Arteriosclerosis. 7:1987;426.
8. Gualandri V., Orsini G.B., Cerrone A., Franceschini G., Sirtori C.R. Familial associations of lipids and lipoproteins in a highly consanguineous population: the Limone sul Garda study. Metabolism. 34:1985;212.
9. Williamson R., Lee D., Hagaman J., Maeda N. Marked reduction of high density lipoprotein cholesterol in mice genetically modified to lack apolipoprotein A-I. Proc Natl Acad Sci USA. 89:1992;7134.
10. 3. J Biol Chem. 264:1989;6488.
11. Schultz J.R., Gong E.L., McCall M.R., Nichols A.V., Clift S.M., Rubin E.M. Expression of human apolipoprotein A-II and its effect on high density lipoproteins in transgenic mice. J Biol Chem. 267:1992;21630.
12. Schultz J.R., Verstuyft J.G., Gong E.L., Nichols A.V., Rubin E.M. Protein composition determines the anti-atherogenic properties of HDL in transgenic mice. Nature. 365:1993;762.
13. Milano apoprotein. Isolation and characterization of a cysteine-containig variant of the A-I apoprotein from human high density lipoproteins. J Clin Invest. 66:1980;901.
14. Allain C.C., Poon L.S., Chan C.S.G., Richmond W., Fu P.C. Enzymatic determination of total serum cholesterol. Clin Chem. 20:1974;470.
15. McGowan M.W., Artiss J.D., Strandbergh D.R., Zak B. A peroxidase-coupled method for the colorimetric determination of serum triglycerides. Clin Chem. 29:1983;538.
16. Lackner C., Boerwinkle E., Leffert C.C., Rahmig T., Hobbs H.H. Molecular basis of apolipoprotein(a) isoform size heterogeneity as revealed by pulsed-field gel electrophoresis. J Clin Invest. 87:1991;2153.
17. Van Gent T., Van Tol A. Automated gel permeation chromatography of plasma lipoproteins by preparative fast protein liquid chromatography. J Chromatogr. 525:1990;433.
18. Lovati M.R., Franceschini G., Allievi L., Dall'Aglio E., Zavaroni I., Sirtori C.R. Endogenous hypertriglyceridemia in a nonobese rat model: plasma lipoproteins and dietary sensitivity. Metabolism. 35:1986;436.
19. Nichols A.V., Krauss R.M., Musliner T.A. Nondenaturing polyacrylamide gradient gel electrophoresis. Methods Enzymol. 128:1986;417.
20. Milano, associated with familial hypoalphalipoproteinemia. J Clin Invest. 91:1993;1445.
21. Milano. Partial lecithin:cholesterol acyltransferase deficiency due to low levels of a functional enzyme. Biochim Biophys Acta. 1043:1990;1.
22. Milano transgenic mice. Abstracts submitted to the Council on Arteriosclerosis for the 68th Scientific Sessions of the American Heart Association, ed. American Heart Association, 1995:39.
23. Calabresi L., Franceschini G., Burkybile A., Jonas A. Activation of lecithin cholesterol acyltransferase by a disulfide-linked apolipoprotein A-I dimer. Biochem Biophys Res Commun. 232:1997;345.
24. Milano apoprotein with plasma lipid and lipoprotein patterns. Atherosclerosis. 58:1985;159.
25. Milano: sex-related differences in the concentration and composition of apo A-I- and apo B-containing lipoprotein particles. J Lipid Res. 34:1993;111.
26. Wang C.S., McConathy W.J., Kloer H.U., Alaupovic P. Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III. J Clin Invest. 75:1985;384.